Gilead Sciences, Inc.

GILD Healthcare Drug Manufacturers General

Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024. In the quarter to June 2026, revenue grew 10.2%, EPS fell 638.2%, free cash flow grew 376.8% and total debt rose 5.21%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for ten consecutive years.

156.19 1.18 −0.75%
Market cap
$195.1B
P/E
0.0×
Fwd P/E
−46.2×
Dividend yield
2.08%
F-score
8/9
Altman Z
4.03
Beneish M
−2.45
Dividend safety
77/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
7.36 20.93 14.89 15.33 582.60 14.67 23.27 18.29 243.08 17.92
Piotroski F-Score
5 5 7 8 6 7 8 7 7 8
P/S ratio
3.27 3.71 3.67 3.68 2.97 3.34 3.93 3.83 4.01 5.19
Altman Z-Score
3.75 2.89 2.82 2.70 1.81 2.44 2.76 2.84 2.74 4.03
Altman Z″-Score (non-manufacturers)
4.85 4.55 4.98 4.29 1.91 2.54 2.45 2.79 2.13 3.28
P/FCF ratio
6.09 8.56 10.86 9.92 9.74 8.44 12.84 14.00 11.18 16.15
Beneish M-Score
(2.88) (3.19) (2.89) (2.62) (2.55) (2.83) (2.80) (2.72) (3.42) (2.45)
P/Operating CF
28.06 35.18 34.62 31.99 38.22 28.46 41.75 47.89 38.72 45.89
Dividend Safety Score
— — — — — — — — — 77
P/B ratio
5.13 4.72 3.77 3.64 4.02 4.33 5.05 4.57 5.98 6.75
EV/Sales
3.78 4.04 3.59 3.73 3.99 4.11 4.66 4.53 4.59 5.77
EV/EBITDA
6.11 6.84 8.25 14.72 17.73 9.39 13.48 11.93 29.78 13.30
EV/FCF
7.04 9.32 10.63 10.07 13.09 10.40 15.24 16.56 12.80 17.98
Current Ratio
2.13 2.74 3.38 3.10 1.40 1.27 1.29 1.43 1.60 1.55
Net Debt/EBITDA
0.78 0.56 (0.18) 0.22 4.54 1.77 2.12 1.85 3.78 1.35
Debt/Equity
1.38 1.66 1.32 1.13 1.79 1.31 1.25 1.15 1.39 1.10
ROE
70.18% 23.22% 25.95% 24.38% 0.60% 31.69% 21.73% 25.77% 2.29% 40.66%
ROA
24.84% 7.27% 8.14% 8.60% 0.19% 9.13% 7.00% 9.04% 0.79% 14.42%
ROIC
32.31% 30.34% 25.87% 11.21% 5.86% 14.68% 11.11% 11.38% 2.89% 15.69%
Return on Tangible Assets
102.01% 19.71% 18.66% 21.51% 1.29% 75.15% 52.90% 55.97% 3.81% 70.13%
Average Days of Receivables
54.22 53.84 54.88 58.24 72.32 60.06 63.91 62.73 56.11 60.91
Earnings Yield
13.59% 4.78% 6.71% 6.53% 0.17% 6.82% 4.30% 5.47% 0.41% 5.58%
Free Cash Flow Yield
16.41% 11.68% 9.21% 10.08% 10.27% 11.85% 7.79% 7.14% 8.95% 6.19%
Free Cash Flow per Share
12.17 8.65 5.76 6.55 5.98 8.60 6.65 5.95 8.26 7.60
Book value per Share
14.46 15.69 16.59 17.83 14.50 16.77 16.90 18.23 15.43 18.18
Free Cash Flow
16,299.00 11,308.00 7,476.00 8,319.00 7,518.00 10,805.00 8,344.00 7,421.00 10,305.00 9,456.00
EV/EBIT
6.51 7.47 9.69 19.54 24.18 11.33 17.35 16.16 79.37 16.96
Other line items

Show all line items

Columns are period end dates